{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T03:50:07Z","timestamp":1784173807778,"version":"3.55.0"},"reference-count":141,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T00:00:00Z","timestamp":1724630400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T00:00:00Z","timestamp":1724630400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004761","name":"the Natural Science Foundation of Hunan Province, China","doi-asserted-by":"crossref","award":["2020JJ4780"],"award-info":[{"award-number":["2020JJ4780"]}],"id":[{"id":"10.13039\/501100004761","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81672688"],"award-info":[{"award-number":["81672688"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Physiol Biochem"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1007\/s13105-024-01041-y","type":"journal-article","created":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T03:08:36Z","timestamp":1724641716000},"page":"775-793","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Inhibin subunit beta B (INHBB): an emerging role in tumor progression"],"prefix":"10.1007","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-1607-6648","authenticated-orcid":false,"given":"Ying","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0069-559X","authenticated-orcid":false,"given":"Qing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0719-9975","authenticated-orcid":false,"given":"Guoying","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1586-6363","authenticated-orcid":false,"given":"Wenling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,26]]},"reference":[{"key":"1041_CR1","doi-asserted-by":"publisher","first-page":"e47312","DOI":"10.1371\/journal.pone.0047312","volume":"7","author":"W Abushahba","year":"2012","unstructured":"Abushahba W, Olabisi OO, Jeong BS, Boregowda RK, Wen Y, Liu F, Goydos JS, Lasfar A, Cohen-Solal KA (2012) Non-canonical smads phosphorylation induced by the glutamate release inhibitor, riluzole, through GSK3 activation in melanoma. PLoS ONE 7:e47312. https:\/\/doi.org\/10.1371\/journal.pone.0047312","journal-title":"PLoS ONE"},{"key":"1041_CR2","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1172\/jci17788","volume":"112","author":"HB Adkins","year":"2003","unstructured":"Adkins HB, Bianco C, Schiffer SG, Rayhorn P, Zafari M, Cheung AE, Orozco O, Olson D, De Luca A, Chen LL, Miatkowski K, Benjamin C, Normanno N, Williams KP, Jarpe M, LePage D, Salomon D, Sanicola M (2003) Antibody blockade of the Cripto CFC domain suppresses tumor cell growth in vivo. J Clin Invest 112:575\u2013587. https:\/\/doi.org\/10.1172\/jci17788","journal-title":"J Clin Invest"},{"key":"1041_CR3","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1006\/bbrc.1998.9170","volume":"249","author":"M Afrakhte","year":"1998","unstructured":"Afrakhte M, Mor\u00e9n A, Jossan S, Itoh S, Sampath K, Westermark B, Heldin CH, Heldin NE, ten Dijke P (1998) Induction of inhibitory Smad6 and Smad7 mRNA by TGF-beta family members. Biochem Biophys Res Commun 249:505\u2013511. https:\/\/doi.org\/10.1006\/bbrc.1998.9170","journal-title":"Biochem Biophys Res Commun"},{"key":"1041_CR4","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1530\/rep.0.1230779","volume":"123","author":"RA Anderson","year":"2002","unstructured":"Anderson RA, Cambray N, Hartley PS, McNeilly AS (2002) Expression and localization of inhibin alpha, inhibin\/activin betaA and betaB and the activin type II and inhibin beta-glycan receptors in the developing human testis. Reproduction 123:779\u2013788. https:\/\/doi.org\/10.1530\/rep.0.1230779","journal-title":"Reproduction"},{"key":"1041_CR5","doi-asserted-by":"publisher","first-page":"155105","DOI":"10.1016\/j.cyto.2020.155105","volume":"133","author":"E Appiah Adu-Gyamfi","year":"2020","unstructured":"Appiah Adu-Gyamfi E, Tanam Djankpa F, Nelson W, Czika A, Kumar Sah S, Lamptey J, Ding YB, Wang YX (2020) Activin and inhibin signaling: from regulation of physiology to involvement in the pathology of the female reproductive system. Cytokine 133:155105. https:\/\/doi.org\/10.1016\/j.cyto.2020.155105","journal-title":"Cytokine"},{"key":"1041_CR6","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.bbrc.2020.05.079","volume":"529","author":"H Bao","year":"2020","unstructured":"Bao H, Sin TK, Zhang G (2020) Activin A induces tumorigenesis of leiomyoma via regulation of p38\u03b2 MAPK-mediated signal cascade. Biochem Biophys Res Commun 529:379\u2013385. https:\/\/doi.org\/10.1016\/j.bbrc.2020.05.079","journal-title":"Biochem Biophys Res Commun"},{"key":"1041_CR7","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.immuni.2019.03.024","volume":"50","author":"E Batlle","year":"2019","unstructured":"Batlle E, Massagu\u00e9 J (2019) Transforming growth Factor-\u03b2 signaling in immunity and Cancer. Immunity 50:924\u2013940. https:\/\/doi.org\/10.1016\/j.immuni.2019.03.024","journal-title":"Immunity"},{"key":"1041_CR8","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1210\/me.2003-0264","volume":"18","author":"DJ Bernard","year":"2004","unstructured":"Bernard DJ (2004) Both SMAD2 and SMAD3 mediate activin-stimulated expression of the follicle-stimulating hormone beta subunit in mouse gonadotrope cells. Mol Endocrinol 18:606\u2013623. https:\/\/doi.org\/10.1210\/me.2003-0264","journal-title":"Mol Endocrinol"},{"key":"1041_CR9","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/1477-7827-4-52","volume":"4","author":"DJ Bernard","year":"2006","unstructured":"Bernard DJ, Lee KB, Santos MM (2006) Activin B can signal through both ALK4 and ALK7 in gonadotrope cells. Reprod Biol Endocrinol 4:52. https:\/\/doi.org\/10.1186\/1477-7827-4-52","journal-title":"Reprod Biol Endocrinol"},{"key":"1041_CR10","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s41420-020-00324-9","volume":"6","author":"G Bildik","year":"2020","unstructured":"Bildik G, Akin N, Esmaeilian Y, Hela F, Yildiz CS, Iltumur E, \u0130ncir S, Karahuseyinoglu S, Yakin K, Oktem O (2020) Terminal differentiation of human granulosa cells as luteinization is reversed by activin-A through silencing of Jnk pathway. Cell Death Discov 6:93. https:\/\/doi.org\/10.1038\/s41420-020-00324-9","journal-title":"Cell Death Discov"},{"key":"1041_CR11","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1210\/mend-5-10-1389","volume":"5","author":"LM Bilezikjian","year":"1991","unstructured":"Bilezikjian LM, Blount AL, Campen CA, Gonzalez-Manchon C, Vale W (1991) Activin-A inhibits proopiomelanocortin messenger RNA accumulation and adrenocorticotropin secretion of AtT20 cells. Mol Endocrinol 5:1389\u20131395. https:\/\/doi.org\/10.1210\/mend-5-10-1389","journal-title":"Mol Endocrinol"},{"key":"1041_CR12","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1210\/endo.142.3.8028","volume":"142","author":"LM Bilezikjian","year":"2001","unstructured":"Bilezikjian LM, Corrigan AZ, Blount AL, Chen Y, Vale WW (2001) Regulation and actions of Smad7 in the modulation of activin, inhibin, and transforming growth factor-beta signaling in anterior pituitary cells. Endocrinology 142:1065\u20131072. https:\/\/doi.org\/10.1210\/endo.142.3.8028","journal-title":"Endocrinology"},{"key":"1041_CR13","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1152\/physrev.00002.2018","volume":"99","author":"E Bloise","year":"2019","unstructured":"Bloise E, Ciarmela P, Dela Cruz C, Luisi S, Petraglia F, Reis FM (2019) Activin A in mammalian physiology. Physiol Rev 99:739\u2013780. https:\/\/doi.org\/10.1152\/physrev.00002.2018","journal-title":"Physiol Rev"},{"key":"1041_CR14","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13058-018-0954-6","volume":"20","author":"JS Brand","year":"2018","unstructured":"Brand JS, Humphreys K, Li J, Karlsson R, Hall P, Czene K (2018) Common genetic variation and novel loci associated with volumetric mammographic density. Breast Cancer Res 20:30. https:\/\/doi.org\/10.1186\/s13058-018-0954-6","journal-title":"Breast Cancer Res"},{"key":"1041_CR15","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1677\/erc-07-0054","volume":"14","author":"JE Burdette","year":"2007","unstructured":"Burdette JE, Woodruff TK (2007) Activin and estrogen crosstalk regulates transcription in human breast cancer cells. Endocr Relat Cancer 14:679\u2013689. https:\/\/doi.org\/10.1677\/erc-07-0054","journal-title":"Endocr Relat Cancer"},{"key":"1041_CR16","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/s0165-0378(98)00014-x","volume":"39","author":"HG Burger","year":"1998","unstructured":"Burger HG, Baillie A, Drummond AE, Healy DL, Jobling T, Mamers P, Robertson DM, Susil B, Cahir N, Shen Y, Verity K, Fuller PJ, Groome NP, Findlay JK (1998) Inhibin and ovarian cancer. J Reprod Immunol 39:77\u201387. https:\/\/doi.org\/10.1016\/s0165-0378(98)00014-x","journal-title":"J Reprod Immunol"},{"key":"1041_CR17","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1007\/s00404-010-1734-4","volume":"284","author":"A Burges","year":"2011","unstructured":"Burges A, Shabani N, Br\u00fcning A, Mylonas I (2011) Inhibin-Betaa and -betab subunits in normal and malignant glandular epithelium of uterine cervix and HeLa cervical cancer cell line. Arch Gynecol Obstet 284:981\u2013988. https:\/\/doi.org\/10.1007\/s00404-010-1734-4","journal-title":"Arch Gynecol Obstet"},{"key":"1041_CR18","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1210\/en.2015-1747","volume":"157","author":"S Canali","year":"2016","unstructured":"Canali S, Core AB, Zumbrennen-Bullough KB, Merkulova M, Wang CY, Schneyer AL, Pietrangelo A, Babitt JL (2016) Activin B induces noncanonical SMAD1\/5\/8 signaling via BMP type I receptors in hepatocytes: evidence for a role in Hepcidin Induction by inflammation in male mice. Endocrinology 157:1146\u20131162. https:\/\/doi.org\/10.1210\/en.2015-1747","journal-title":"Endocrinology"},{"key":"1041_CR19","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/j.molmed.2020.07.009","volume":"26","author":"M Cangkrama","year":"2020","unstructured":"Cangkrama M, Wietecha M, Werner S (2020) Wound repair, scar formation, and Cancer: converging on activin. Trends Mol Med 26:1107\u20131117. https:\/\/doi.org\/10.1016\/j.molmed.2020.07.009","journal-title":"Trends Mol Med"},{"key":"1041_CR20","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.canlet.2020.11.025","volume":"499","author":"Y Chen","year":"2021","unstructured":"Chen Y, Qian B, Sun X, Kang Z, Huang Z, Ding Z, Dong L, Chen J, Zhang J, Zang Y (2021) Sox9\/INHBB axis-mediated crosstalk between the hepatoma and hepatic stellate cells promotes the metastasis of hepatocellular carcinoma. Cancer Lett 499:243\u2013254. https:\/\/doi.org\/10.1016\/j.canlet.2020.11.025","journal-title":"Cancer Lett"},{"key":"1041_CR21","doi-asserted-by":"publisher","first-page":"100037","DOI":"10.1074\/jbc.RA120.014793","volume":"296","author":"X Chen","year":"2021","unstructured":"Chen X, Zhao C, Xu Y, Huang K, Wang Y, Wang X, Zhou X, Pang W, Yang G, Yu T (2021) Adipose-specific BMP and activin membrane-bound inhibitor (BAMBI) deletion promotes adipogenesis by accelerating ROS production. J Biol Chem 296:100037. https:\/\/doi.org\/10.1074\/jbc.RA120.014793","journal-title":"J Biol Chem"},{"key":"1041_CR22","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1530\/eje.0.1450779","volume":"145","author":"L Cobellis","year":"2001","unstructured":"Cobellis L, Cataldi P, Reis FM, De Palo G, Raspagliesi F, Pilotti S, Arcuri F, Petraglia F (2001) Gonadal malignant germ cell tumors express immunoreactive inhibin\/activin subunits. Eur J Endocrinol 145:779\u2013784. https:\/\/doi.org\/10.1530\/eje.0.1450779","journal-title":"Eur J Endocrinol"},{"key":"1041_CR23","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1152\/physrev.1988.68.2.555","volume":"68","author":"FH De Jong","year":"1988","unstructured":"De Jong FH (1988) Inhibin. Physiol Rev 68:555\u2013607. https:\/\/doi.org\/10.1152\/physrev.1988.68.2.555","journal-title":"Physiol Rev"},{"key":"1041_CR24","doi-asserted-by":"publisher","first-page":"e20253","DOI":"10.1097\/md.0000000000020253","volume":"99","author":"SK Deng","year":"2020","unstructured":"Deng SK, Tang JZ, Jin Y, Hu PH, Wang JF, Zhang XW (2020) Activin B signaling may promote the conversion of normal fibroblasts to scar fibroblasts. Med (Baltim) 99:e20253. https:\/\/doi.org\/10.1097\/md.0000000000020253","journal-title":"Med (Baltim)"},{"key":"1041_CR25","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41571-020-0403-1","volume":"18","author":"R Derynck","year":"2021","unstructured":"Derynck R, Turley SJ, Akhurst RJ (2021) TGF\u03b2 biology in cancer progression and immunotherapy. Nat Rev Clin Oncol 18:9\u201334. https:\/\/doi.org\/10.1038\/s41571-020-0403-1","journal-title":"Nat Rev Clin Oncol"},{"key":"1041_CR26","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1158\/1055-9965.Epi-10-0719","volume":"20","author":"J Devaney","year":"2011","unstructured":"Devaney J, Stirzaker C, Qu W, Song JZ, Statham AL, Patterson KI, Horvath LG, Tabor B, Coolen MW, Hulf T, Kench JG, Henshall SM, Pe Benito R, Haynes AM, Mayor R, Peinado MA, Sutherland RL, Clark SJ (2011) Epigenetic deregulation across chromosome 2q14.2 differentiates normal from prostate cancer and provides a regional panel of novel DNA methylation cancer biomarkers. Cancer Epidemiol Biomarkers Prev 20:148\u2013159. https:\/\/doi.org\/10.1158\/1055-9965.Epi-10-0719","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1041_CR27","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1530\/eje.0.1410190","volume":"141","author":"C Di Loreto","year":"1999","unstructured":"Di Loreto C, Reis FM, Cataldi P, Zuiani C, Luisi S, Beltrami CA, Petraglia F (1999) Human mammary gland and breast carcinoma contain immunoreactive inhibin\/activin subunits: evidence for a secretion into cystic fluid. Eur J Endocrinol 141:190\u2013194. https:\/\/doi.org\/10.1530\/eje.0.1410190","journal-title":"Eur J Endocrinol"},{"key":"1041_CR28","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13045-020-00937-8","volume":"13","author":"R Duan","year":"2020","unstructured":"Duan R, Du W, Guo W (2020) EZH2: a novel target for cancer treatment. J Hematol Oncol 13:104. https:\/\/doi.org\/10.1186\/s13045-020-00937-8","journal-title":"J Hematol Oncol"},{"key":"1041_CR29","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/1471-2350-13-53","volume":"13","author":"N Eriksson","year":"2012","unstructured":"Eriksson N, Benton GM, Do CB, Kiefer AK, Mountain JL, Hinds DA, Francke U, Tung JY (2012) Genetic variants associated with breast size also influence breast cancer risk. BMC Med Genet 13:53. https:\/\/doi.org\/10.1186\/1471-2350-13-53","journal-title":"BMC Med Genet"},{"key":"1041_CR30","doi-asserted-by":"publisher","first-page":"C428","DOI":"10.1152\/ajpcell.00178.2022","volume":"324","author":"ET Evans","year":"2023","unstructured":"Evans ET, Horst B, Arend RC, Mythreye K (2023) Evolving roles of activins and inhibins in ovarian cancer pathophysiology. Am J Physiol Cell Physiol 324:C428\u2013c437. https:\/\/doi.org\/10.1152\/ajpcell.00178.2022","journal-title":"Am J Physiol Cell Physiol"},{"key":"1041_CR31","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1152\/physrev.00008.2013","volume":"93","author":"T Ganz","year":"2013","unstructured":"Ganz T (2013) Systemic iron homeostasis. Physiol Rev 93:1721\u20131741. https:\/\/doi.org\/10.1152\/physrev.00008.2013","journal-title":"Physiol Rev"},{"key":"1041_CR32","doi-asserted-by":"publisher","first-page":"17349","DOI":"10.1073\/pnas.1102297108","volume":"108","author":"E Geh","year":"2011","unstructured":"Geh E, Meng Q, Mongan M, Wang J, Takatori A, Zheng Y, Puga A, Lang RA, Xia Y (2011) Mitogen-activated protein kinase kinase kinase 1 (MAP3K1) integrates developmental signals for eyelid closure. Proc Natl Acad Sci U S A 108:17349\u201317354. https:\/\/doi.org\/10.1073\/pnas.1102297108","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1041_CR33","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.bbagrm.2017.02.003","volume":"1860","author":"S Gherardi","year":"2017","unstructured":"Gherardi S, Ripoche D, Mikaelian I, Chanal M, Teinturier R, Goehrig D, Cordier-Bussat M, Zhang CX, Hennino A, Bertolino P (2017) Menin regulates Inhbb expression through an Akt\/Ezh2-mediated H3K27 histone modification. Biochim Biophys Acta Gene Regul Mech 1860:427\u2013437. https:\/\/doi.org\/10.1016\/j.bbagrm.2017.02.003","journal-title":"Biochim Biophys Acta Gene Regul Mech"},{"key":"1041_CR34","first-page":"2011","volume":"27","author":"A Gingelmaier","year":"2007","unstructured":"Gingelmaier A, Gutsche S, Mylonas I, Shabani N, Kuhn C, Kunze S, Jeschke U, Friese K (2007) Expression of HPV, steroid receptors (ERalpha, ERbeta, PR-A and PR-B) and inhibin\/activin subunits (alpha, betaA and betaB) in adenosquamous endometrial carcinoma. Anticancer Res 27:2011\u20132017","journal-title":"Anticancer Res"},{"key":"1041_CR35","doi-asserted-by":"publisher","unstructured":"Grafe I, Alexander S, Peterson JR, Snider TN, Levi B, Lee B, Mishina Y (2018) TGF-\u03b2 Family Signaling in Mesenchymal differentiation. Cold Spring Harb Perspect Biol 10. https:\/\/doi.org\/10.1101\/cshperspect.a022202","DOI":"10.1101\/cshperspect.a022202"},{"key":"1041_CR36","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1016\/j.febslet.2012.01.051","volume":"586","author":"PC Gray","year":"2012","unstructured":"Gray PC, Vale W (2012) Cripto\/GRP78 modulation of the TGF-\u03b2 pathway in development and oncogenesis. FEBS Lett 586:1836\u20131845. https:\/\/doi.org\/10.1016\/j.febslet.2012.01.051","journal-title":"FEBS Lett"},{"key":"1041_CR37","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/s0303-7207(01)00515-9","volume":"180","author":"PC Gray","year":"2001","unstructured":"Gray PC, Bilezikjian LM, Vale W (2001) Antagonism of activin by inhibin and inhibin receptors: a functional role for betaglycan-glycan. Mol Cell Endocrinol 180:47\u201353. https:\/\/doi.org\/10.1016\/s0303-7207(01)00515-9","journal-title":"Mol Cell Endocrinol"},{"key":"1041_CR38","doi-asserted-by":"publisher","first-page":"5193","DOI":"10.1073\/pnas.0531290100","volume":"100","author":"PC Gray","year":"2003","unstructured":"Gray PC, Harrison CA, Vale W (2003) Cripto forms a complex with activin and type II activin receptors and can block activin signaling. Proc Natl Acad Sci U S A 100:5193\u20135198. https:\/\/doi.org\/10.1073\/pnas.0531290100","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1041_CR39","doi-asserted-by":"publisher","unstructured":"Gutierrez A, Demond H, Brebi P, Ili CG (2021) Novel methylation biomarkers for Colorectal Cancer Prognosis. https:\/\/doi.org\/10.3390\/biom11111722. Biomolecules 11","DOI":"10.3390\/biom11111722"},{"key":"1041_CR40","doi-asserted-by":"publisher","unstructured":"Hata A, Chen YG (2016) TGF-\u03b2 signaling from receptors to Smads. Cold Spring Harb Perspect Biol 8. https:\/\/doi.org\/10.1101\/cshperspect.a022061","DOI":"10.1101\/cshperspect.a022061"},{"key":"1041_CR41","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/b978-0-12-385961-7.00013-5","volume":"85","author":"MP Hedger","year":"2011","unstructured":"Hedger MP, Winnall WR, Phillips DJ, de Kretser DM (2011) The regulation and functions of activin and follistatin in inflammation and immunity. Vitam Horm 85:255\u2013297. https:\/\/doi.org\/10.1016\/b978-0-12-385961-7.00013-5","journal-title":"Vitam Horm"},{"key":"1041_CR42","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1158\/1055-9965.Epi-19-0675","volume":"29","author":"SR Irvin","year":"2020","unstructured":"Irvin SR, Weiderpass E, Stanczyk FZ, Brinton LA, Trabert B, Langseth H, Wentzensen N (2020) Association of anti-mullerian hormone, follicle-stimulating hormone, and Inhibin B with Risk of Ovarian Cancer in the Janus Serum Bank. Cancer Epidemiol Biomarkers Prev 29:636\u2013642. https:\/\/doi.org\/10.1158\/1055-9965.Epi-19-0675","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1041_CR43","doi-asserted-by":"publisher","first-page":"2746","DOI":"10.1158\/0008-5472.Can-16-2183","volume":"77","author":"L Jiang","year":"2017","unstructured":"Jiang L, Hermeking H (2017) miR-34a and miR-34b\/c suppress intestinal tumorigenesis. Cancer Res 77:2746\u20132758. https:\/\/doi.org\/10.1158\/0008-5472.Can-16-2183","journal-title":"Cancer Res"},{"key":"1041_CR44","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1111\/IGC.0b013e3181ef10aa","volume":"20","author":"J J\u00fcckstock","year":"2010","unstructured":"J\u00fcckstock J, Br\u00fcning A, Blankenstein T, Kunze S, Shabani N, Bergauer F, Mylonas I (2010) Immunolabeling of the inhibin-\u03b2A and -\u03b2B subunit in normal and malignant human cervical tissue and cervical cancer cell lines. Int J Gynecol Cancer 20:1117\u20131124. https:\/\/doi.org\/10.1111\/IGC.0b013e3181ef10aa","journal-title":"Int J Gynecol Cancer"},{"key":"1041_CR45","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1053\/j.gastro.2016.10.015","volume":"152","author":"B Jung","year":"2017","unstructured":"Jung B, Staudacher JJ, Beauchamp D (2017) Transforming growth factor \u03b2 Superfamily Signaling in Development of Colorectal Cancer. Gastroenterology 152:36\u201352. https:\/\/doi.org\/10.1053\/j.gastro.2016.10.015","journal-title":"Gastroenterology"},{"key":"1041_CR46","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3389\/fonc.2019.00032","volume":"9","author":"M Kalli","year":"2019","unstructured":"Kalli M, Mpekris F, Wong CK, Panagi M, Ozturk S, Thiagalingam S, Stylianopoulos T, Papageorgis P (2019) Activin A Signaling regulates IL13R\u03b12 expression to promote breast Cancer metastasis. Front Oncol 9:32. https:\/\/doi.org\/10.3389\/fonc.2019.00032","journal-title":"Front Oncol"},{"key":"1041_CR47","doi-asserted-by":"publisher","first-page":"38702","DOI":"10.1038\/srep38702","volume":"6","author":"Y Kanamori","year":"2016","unstructured":"Kanamori Y, Sugiyama M, Hashimoto O, Murakami M, Matsui T, Funaba M (2016) Regulation of hepcidin expression by inflammation-induced activin B. Sci Rep 6:38702. https:\/\/doi.org\/10.1038\/srep38702","journal-title":"Sci Rep"},{"key":"1041_CR48","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1158\/1541-7786.Mcr-07-2158","volume":"6","author":"P Karpinski","year":"2008","unstructured":"Karpinski P, Ramsey D, Grzebieniak Z, Sasiadek MM, Blin N (2008) The CpG island methylator phenotype correlates with long-range epigenetic silencing in colorectal cancer. Mol Cancer Res 6:585\u2013591. https:\/\/doi.org\/10.1158\/1541-7786.Mcr-07-2158","journal-title":"Mol Cancer Res"},{"key":"1041_CR49","doi-asserted-by":"publisher","first-page":"4490","DOI":"10.1074\/jbc.M704960200","volume":"283","author":"JA Kelber","year":"2008","unstructured":"Kelber JA, Shani G, Booker EC, Vale WW, Gray PC (2008) Cripto is a noncompetitive activin antagonist that forms analogous signaling complexes with activin and nodal. J Biol Chem 283:4490\u20134500. https:\/\/doi.org\/10.1074\/jbc.M704960200","journal-title":"J Biol Chem"},{"key":"1041_CR50","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1038\/onc.2009.97","volume":"28","author":"JA Kelber","year":"2009","unstructured":"Kelber JA, Panopoulos AD, Shani G, Booker EC, Belmonte JC, Vale WW, Gray PC (2009) Blockade of Cripto binding to cell surface GRP78 inhibits oncogenic Cripto signaling via MAPK\/PI3K and Smad2\/3 pathways. Oncogene 28:2324\u20132336. https:\/\/doi.org\/10.1038\/onc.2009.97","journal-title":"Oncogene"},{"key":"1041_CR51","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1124\/jpet.116.232322","volume":"358","author":"AM Khalil","year":"2016","unstructured":"Khalil AM, Dotimas H, Kahn J, Lamerdin JE, Hayes DB, Gupta P, Franti M (2016) Differential binding activity of TGF-\u03b2 family proteins to select TGF-\u03b2 receptors. J Pharmacol Exp Ther 358:423\u2013430. https:\/\/doi.org\/10.1124\/jpet.116.232322","journal-title":"J Pharmacol Exp Ther"},{"key":"1041_CR52","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.7150\/jca.18714","volume":"8","author":"A Kita","year":"2017","unstructured":"Kita A, Kasamatsu A, Nakashima D, Endo-Sakamoto Y, Ishida S, Shimizu T, Kimura Y, Miyamoto I, Yoshimura S, Shiiba M, Tanzawa H, Uzawa K (2017) Activin B regulates adhesion, invasiveness, and migratory activities in oral Cancer: a potential biomarker for Metastasis. J Cancer 8:2033\u20132041. https:\/\/doi.org\/10.7150\/jca.18714","journal-title":"J Cancer"},{"key":"1041_CR53","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1530\/rep.0.1210503","volume":"121","author":"PG Knight","year":"2001","unstructured":"Knight PG, Glister C (2001) Potential local regulatory functions of inhibins, activins and follistatin in the ovary. Reproduction 121:503\u2013512. https:\/\/doi.org\/10.1530\/rep.0.1210503","journal-title":"Reproduction"},{"key":"1041_CR54","doi-asserted-by":"publisher","unstructured":"Lachat C, Bruy\u00e8re D, Etcheverry A, Aubry M, Mosser J, Warda W, Herfs M, Hendrick E, Ferrand C, Borg C, Delage-Mourroux R, Feugeas JP, Guittaut M, Hervouet E, Peixoto P (2020) EZH2 and KDM6B expressions are Associated with specific epigenetic signatures during EMT in non small cell lung carcinomas. Cancers (Basel) 12. https:\/\/doi.org\/10.3390\/cancers12123649","DOI":"10.3390\/cancers12123649"},{"key":"1041_CR55","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1128\/mcb.17.3.1682","volume":"17","author":"JJ Lebrun","year":"1997","unstructured":"Lebrun JJ, Vale WW (1997) Activin and inhibin have antagonistic effects on ligand-dependent heteromerization of the type I and type II activin receptors and human erythroid differentiation. Mol Cell Biol 17:1682\u20131691. https:\/\/doi.org\/10.1128\/mcb.17.3.1682","journal-title":"Mol Cell Biol"},{"key":"1041_CR56","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12967-017-1161-4","volume":"15","author":"BA Lidbury","year":"2017","unstructured":"Lidbury BA, Kita B, Lewis DP, Hayward S, Ludlow H, Hedger MP, de Kretser DM (2017) Activin B is a novel biomarker for chronic fatigue syndrome\/myalgic encephalomyelitis (CFS\/ME) diagnosis: a cross sectional study. J Transl Med 15:60. https:\/\/doi.org\/10.1186\/s12967-017-1161-4","journal-title":"J Transl Med"},{"key":"1041_CR57","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1038\/321779a0","volume":"321","author":"N Ling","year":"1986","unstructured":"Ling N, Ying SY, Ueno N, Shimasaki S, Esch F, Hotta M, Guillemin R (1986) Pituitary FSH is released by a heterodimer of the beta-subunits from the two forms of inhibin. Nature 321:779\u2013782. https:\/\/doi.org\/10.1038\/321779a0","journal-title":"Nature"},{"key":"1041_CR58","doi-asserted-by":"publisher","first-page":"e58350","DOI":"10.1371\/journal.pone.0058350","volume":"8","author":"J Long","year":"2013","unstructured":"Long J, Zhang B, Signorello LB, Cai Q, Deming-Halverson S, Shrubsole MJ, Sanderson M, Dennis J, Michailidou K, Easton DF, Shu XO, Blot WJ, Zheng W (2013) Evaluating genome-wide association study-identified breast cancer risk variants in African-American women. PLoS ONE 8:e58350. https:\/\/doi.org\/10.1371\/journal.pone.0058350","journal-title":"PLoS ONE"},{"key":"1041_CR59","first-page":"2431","volume":"6","author":"HA Loomans","year":"2016","unstructured":"Loomans HA, Andl CD (2016) Activin receptor-like kinases: a diverse family playing an important role in cancer. Am J Cancer Res 6:2431\u20132447","journal-title":"Am J Cancer Res"},{"key":"1041_CR60","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1530\/erc-21-0017","volume":"28","author":"KA Luckett","year":"2021","unstructured":"Luckett KA, Cracchiolo JR, Krishnamoorthy GP, Leandro-Garcia LJ, Nagarajah J, Saqcena M, Lester R, Im SY, Zhao Z, Lowe SW, de Stanchina E, Sherman EJ, Ho AL, Leach SD, Knauf JA, Fagin JA (2021) Co-inhibition of SMAD and MAPK signaling enhances 124I uptake in BRAF-mutant thyroid cancers. Endocr Relat Cancer 28:391\u2013402. https:\/\/doi.org\/10.1530\/erc-21-0017","journal-title":"Endocr Relat Cancer"},{"key":"1041_CR61","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1530\/eje.0.1430705","volume":"143","author":"H Machida","year":"2000","unstructured":"Machida H, Ogawa K, Funaba M, Mizutani T, Tsujimoto M (2000) mRNA expression of type I and type II receptors for activin, transforming growth factor-beta, and bone morphogenetic protein in the murine erythroleukemic cell line, F5-5.Fl. Eur J Endocrinol 143:705\u2013710. https:\/\/doi.org\/10.1530\/eje.0.1430705","journal-title":"Eur J Endocrinol"},{"key":"1041_CR62","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.bbrc.2010.04.022","volume":"395","author":"B Magnusson","year":"2010","unstructured":"Magnusson B, Svensson PA, Carlsson LM, Sj\u00f6holm K (2010) Activin B inhibits lipolysis in 3T3-L1 adipocytes. Biochem Biophys Res Commun 395:373\u2013376. https:\/\/doi.org\/10.1016\/j.bbrc.2010.04.022","journal-title":"Biochem Biophys Res Commun"},{"key":"1041_CR63","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1210\/er.2014-1003","volume":"35","author":"Y Makanji","year":"2014","unstructured":"Makanji Y, Zhu J, Mishra R, Holmquist C, Wong WP, Schwartz NB, Mayo KE, Woodruff TK (2014) Inhibin at 90: from discovery to clinical application, a historical review. Endocr Rev 35:747\u2013794. https:\/\/doi.org\/10.1210\/er.2014-1003","journal-title":"Endocr Rev"},{"key":"1041_CR64","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/s1091-255x(00)80075-x","volume":"4","author":"TS Maldonado","year":"2000","unstructured":"Maldonado TS, Kadison AS, Crisera CA, Grau JB, Alkasab SL, Longaker MT, Gittes GK (2000) Ontogeny of activin B and follistatin in developing embryonic mouse pancreas: implications for lineage selection. J Gastrointest Surg 4:269\u2013275. https:\/\/doi.org\/10.1016\/s1091-255x(00)80075-x","journal-title":"J Gastrointest Surg"},{"key":"1041_CR65","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1089\/105072503321582033","volume":"13","author":"SE Matsuo","year":"2003","unstructured":"Matsuo SE, Ebina KN, Kulcsar MA, Friguglietti CU, Kimura ET (2003) Activin betaB expression in rat experimental goiter and human thyroid tumors. Thyroid 13:239\u2013247. https:\/\/doi.org\/10.1089\/105072503321582033","journal-title":"Thyroid"},{"key":"1041_CR66","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1038\/sj.bjc.6605045","volume":"100","author":"R Mayor","year":"2009","unstructured":"Mayor R, Casadom\u00e9 L, Azuara D, Moreno V, Clark SJ, Capell\u00e0 G, Peinado MA (2009) Long-range epigenetic silencing at 2q14.2 affects most human colorectal cancers and may have application as a non-invasive biomarker of disease. Br J Cancer 100:1534\u20131539. https:\/\/doi.org\/10.1038\/sj.bjc.6605045","journal-title":"Br J Cancer"},{"key":"1041_CR67","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1126\/science.76.1957.19","volume":"76","author":"DR McCullagh","year":"1932","unstructured":"McCullagh DR (1932) DUAL ENDOCRINE ACTIVITY OF THE TESTES. Science 76:19\u201320. https:\/\/doi.org\/10.1126\/science.76.1957.19","journal-title":"Science"},{"key":"1041_CR68","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1677\/joe.0.1540535","volume":"154","author":"SJ McPherson","year":"1997","unstructured":"McPherson SJ, Thomas TZ, Wang H, Gurusinghe CJ, Risbridger GP (1997) Growth inhibitory response to activin A and B by human prostate tumour cell lines, LNCaP and DU145. J Endocrinol 154:535\u2013545. https:\/\/doi.org\/10.1677\/joe.0.1540535","journal-title":"J Endocrinol"},{"key":"1041_CR69","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1210\/jcem.83.3.4640","volume":"83","author":"SL Mellor","year":"1998","unstructured":"Mellor SL, Richards MG, Pedersen JS, Robertson DM, Risbridger GP (1998) Loss of the expression and localization of inhibin alpha-subunit in high grade prostate cancer. J Clin Endocrinol Metab 83:969\u2013975. https:\/\/doi.org\/10.1210\/jcem.83.3.4640","journal-title":"J Clin Endocrinol Metab"},{"key":"1041_CR70","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/s13238-011-1113-3","volume":"2","author":"Q Meng","year":"2011","unstructured":"Meng Q, Xia Y (2011) c-Jun, at the crossroad of the signaling network. Protein Cell 2:889\u2013898. https:\/\/doi.org\/10.1007\/s13238-011-1113-3","journal-title":"Protein Cell"},{"key":"1041_CR71","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.devcel.2019.04.015","volume":"49","author":"IP Michael","year":"2019","unstructured":"Michael IP, Saghafinia S, Tichet M, Zangger N, Marinoni I, Perren A, Hanahan D (2019) ALK7 Signaling manifests a homeostatic tissue barrier that is abrogated during Tumorigenesis and metastasis. Dev Cell 49:409\u2013424e406. https:\/\/doi.org\/10.1016\/j.devcel.2019.04.015","journal-title":"Dev Cell"},{"issue":"Pt 7","key":"1041_CR72","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1242\/jcs.113.7.1101","volume":"113","author":"K Miyazono","year":"2000","unstructured":"Miyazono K (2000) Positive and negative regulation of TGF-beta signaling. J Cell Sci 113(Pt 7):1101\u20131109","journal-title":"J Cell Sci"},{"key":"1041_CR73","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1016\/j.ejca.2010.06.001","volume":"46","author":"I Mylonas","year":"2010","unstructured":"Mylonas I (2010) Inhibin-alpha, -betaA and -betab subunits in uterine non-endometrioid carcinomas: prognostic significance and clinical implications. Eur J Cancer 46:2485\u20132493. https:\/\/doi.org\/10.1016\/j.ejca.2010.06.001","journal-title":"Eur J Cancer"},{"key":"1041_CR74","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.14670\/hh-26.1415","volume":"26","author":"I Mylonas","year":"2011","unstructured":"Mylonas I (2011) Inhibin beta B: a useful tumor marker in uterine endometrioid adenocarcinomas? Histol Histopathol 26:1415\u20131422. https:\/\/doi.org\/10.14670\/hh-26.1415","journal-title":"Histol Histopathol"},{"key":"1041_CR75","doi-asserted-by":"publisher","first-page":"887","DOI":"10.3892\/or.2011.1379","volume":"26","author":"I Mylonas","year":"2011","unstructured":"Mylonas I, Dian D (2011) Inhibin-\u03b1 subunit in normal and malignant human cervical tissue and cervical cancer cell lines. Oncol Rep 26:887\u2013891. https:\/\/doi.org\/10.3892\/or.2011.1379","journal-title":"Oncol Rep"},{"key":"1041_CR76","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s00418-004-0709-6","volume":"122","author":"I Mylonas","year":"2004","unstructured":"Mylonas I, Jeschke U, Wiest I, Hoeing A, Vogl J, Shabani N, Kuhn C, Schulze S, Kupka MS, Friese K (2004) Inhibin\/activin subunits alpha, beta-A and beta-B are differentially expressed in normal human endometrium throughout the menstrual cycle. Histochem Cell Biol 122:461\u2013471. https:\/\/doi.org\/10.1007\/s00418-004-0709-6","journal-title":"Histochem Cell Biol"},{"key":"1041_CR77","first-page":"81","volume":"13","author":"I Mylonas","year":"2005","unstructured":"Mylonas I, Jeschke U, Shabani N, Kuhn C, Friese K, Gerber B (2005) Inhibin\/activin subunits (inhibin-alpha, -betaA and -betab) are differentially expressed in human breast cancer and their metastasis. Oncol Rep 13:81\u201388","journal-title":"Oncol Rep"},{"key":"1041_CR78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.acthis.2005.11.002","volume":"108","author":"I Mylonas","year":"2006","unstructured":"Mylonas I, Makovitzky J, Hoeing A, Richter DU, Vogl J, Schulze S, Jeschke U, Briese V, Friese K (2006) Inhibin\/activin subunits beta-A (-betaA) and beta-B (-betaB) are differentially localised in normal, hyperplastic and malignant human endometrial tissue. Acta Histochem 108:1\u201311. https:\/\/doi.org\/10.1016\/j.acthis.2005.11.002","journal-title":"Acta Histochem"},{"key":"1041_CR79","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.ejca.2009.01.008","volume":"45","author":"I Mylonas","year":"2009","unstructured":"Mylonas I, Worbs S, Shabani N, Kuhn C, Kunze S, Schulze S, Dian D, Gingelmaier A, Schindlbeck C, Br\u00fcning A, Sommer H, Jeschke U, Friese K (2009) Inhibin-alpha subunit is an independent prognostic parameter in human endometrial carcinomas: analysis of inhibin\/activin-alpha, -betaA and -betab subunits in 302 cases. Eur J Cancer 45:1304\u20131314. https:\/\/doi.org\/10.1016\/j.ejca.2009.01.008","journal-title":"Eur J Cancer"},{"key":"1041_CR80","doi-asserted-by":"publisher","first-page":"100864","DOI":"10.1016\/j.mam.2020.100864","volume":"75","author":"M Nairz","year":"2020","unstructured":"Nairz M, Weiss G (2020) Iron in infection and immunity. Mol Aspects Med 75:100864. https:\/\/doi.org\/10.1016\/j.mam.2020.100864","journal-title":"Mol Aspects Med"},{"key":"1041_CR81","doi-asserted-by":"publisher","first-page":"5353","DOI":"10.1093\/emboj\/16.17.5353","volume":"16","author":"A Nakao","year":"1997","unstructured":"Nakao A, Imamura T, Souchelnytskyi S, Kawabata M, Ishisaki A, Oeda E, Tamaki K, Hanai J, Heldin CH, Miyazono K, ten Dijke P (1997) TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4. Embo j 16:5353\u20135362. https:\/\/doi.org\/10.1093\/emboj\/16.17.5353","journal-title":"Embo j"},{"key":"1041_CR82","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1093\/abbs\/gmx126","volume":"50","author":"J Nickel","year":"2018","unstructured":"Nickel J, Ten Dijke P, Mueller TD (2018) TGF-\u03b2 family co-receptor function and signaling. Acta Biochim Biophys Sin (Shanghai) 50:12\u201336. https:\/\/doi.org\/10.1093\/abbs\/gmx126","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"1041_CR83","doi-asserted-by":"publisher","unstructured":"Olsen OE, Hella H, Elsaadi S, Jacobi C, Martinez-Hackert E, Holien T (2020) Activins as dual specificity TGF-\u03b2 family molecules: SMAD-Activation via activin- and BMP-Type 1 receptors. https:\/\/doi.org\/10.3390\/biom10040519. Biomolecules 10","DOI":"10.3390\/biom10040519"},{"key":"1041_CR84","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/46794","volume":"401","author":"D Onichtchouk","year":"1999","unstructured":"Onichtchouk D, Chen YG, Dosch R, Gawantka V, Delius H, Massagu\u00e9 J, Niehrs C (1999) Silencing of TGF-beta signalling by the pseudoreceptor BAMBI. Nature 401:480\u2013485. https:\/\/doi.org\/10.1038\/46794","journal-title":"Nature"},{"key":"1041_CR85","doi-asserted-by":"publisher","first-page":"4461","DOI":"10.1210\/en.2016-1580","volume":"157","author":"C Pan","year":"2016","unstructured":"Pan C, Singh S, Sahasrabudhe DM, Chakkalakal JV, Krolewski JJ, Nastiuk KL (2016) TGF\u03b2 superfamily members mediate Androgen Deprivation Therapy-Induced obese frailty in male mice. Endocrinology 157:4461\u20134472. https:\/\/doi.org\/10.1210\/en.2016-1580","journal-title":"Endocrinology"},{"key":"1041_CR86","doi-asserted-by":"publisher","unstructured":"Pickup MW, Owens P, Moses HL (2017) TGF-\u03b2, bone morphogenetic protein, and activin signaling and the Tumor Microenvironment. Cold Spring Harb Perspect Biol 9. https:\/\/doi.org\/10.1101\/cshperspect.a022285","DOI":"10.1101\/cshperspect.a022285"},{"key":"1041_CR87","doi-asserted-by":"publisher","first-page":"25500","DOI":"10.18632\/oncotarget.16064","volume":"8","author":"Z Qian","year":"2017","unstructured":"Qian Z, Zhang G, Song G, Shi J, Gong L, Mou Y, Han Y (2017) Integrated analysis of genes associated with poor prognosis of patients with colorectal cancer liver metastasis. Oncotarget 8:25500\u201325512. https:\/\/doi.org\/10.18632\/oncotarget.16064","journal-title":"Oncotarget"},{"key":"1041_CR88","doi-asserted-by":"publisher","unstructured":"Reader KL, John-McHaffie S, Zellhuber-McMillan S, Jowett T, Mottershead DG, Cunliffe HE, Gold EJ (2022) Activin B and activin C have Opposing effects on prostate Cancer progression and cell growth. Cancers (Basel) 15. https:\/\/doi.org\/10.3390\/cancers15010147","DOI":"10.3390\/cancers15010147"},{"key":"1041_CR89","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1186\/s12885-016-2914-9","volume":"16","author":"B Refaat","year":"2016","unstructured":"Refaat B, El-Shemi AG, Mohamed AM, Kensara OA, Ahmad J, Idris S (2016) Activins and their related proteins in colon carcinogenesis: insights from early and advanced azoxymethane rat models of colon cancer. BMC Cancer 16:879. https:\/\/doi.org\/10.1186\/s12885-016-2914-9","journal-title":"BMC Cancer"},{"key":"1041_CR90","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1128\/mcb.00930-15","volume":"36","author":"D Ripoche","year":"2015","unstructured":"Ripoche D, Charbord J, Hennino A, Teinturier R, Bonnavion R, Jaafar R, Goehrig D, Cordier-Bussat M, Ritvos O, Zhang CX, Andersson O, Bertolino P (2015) ActivinB is Induced in Insulinoma to promote Tumor plasticity through a \u03b2-Cell-Induced dedifferentiation. Mol Cell Biol 36:756\u2013764. https:\/\/doi.org\/10.1128\/mcb.00930-15","journal-title":"Mol Cell Biol"},{"key":"1041_CR91","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1210\/jcem.77.5.8077341","volume":"77","author":"VJ Roberts","year":"1993","unstructured":"Roberts VJ, Barth S, el-Roeiy A, Yen SS (1993) Expression of inhibin\/activin subunits and follistatin messenger ribonucleic acids and proteins in ovarian follicles and the corpus luteum during the human menstrual cycle. J Clin Endocrinol Metab 77:1402\u20131410. https:\/\/doi.org\/10.1210\/jcem.77.5.8077341","journal-title":"J Clin Endocrinol Metab"},{"key":"1041_CR92","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1210\/jcem.86.5.7446","volume":"86","author":"K Salmenkivi","year":"2001","unstructured":"Salmenkivi K, Arola J, Voutilainen R, Ilvesm\u00e4ki V, Haglund C, Kahri AI, Heikkil\u00e4 P, Liu J (2001) Inhibin\/activin betab-subunit expression in pheochromocytomas favors benign diagnosis. J Clin Endocrinol Metab 86:2231\u20132235. https:\/\/doi.org\/10.1210\/jcem.86.5.7446","journal-title":"J Clin Endocrinol Metab"},{"key":"1041_CR93","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s11010-016-2671-8","volume":"414","author":"F Sangkop","year":"2016","unstructured":"Sangkop F, Singh G, Rodrigues E, Gold E, Bahn A (2016) Uric acid: a modulator of prostate cells and activin sensitivity. Mol Cell Biochem 414:187\u2013199. https:\/\/doi.org\/10.1007\/s11010-016-2671-8","journal-title":"Mol Cell Biochem"},{"key":"1041_CR94","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1210\/en.2019-00015","volume":"160","author":"DD Seachrist","year":"2019","unstructured":"Seachrist DD, Keri RA (2019) The activin Social Network: activin, Inhibin, and follistatin in breast development and Cancer. Endocrinology 160:1097\u20131110. https:\/\/doi.org\/10.1210\/en.2019-00015","journal-title":"Endocrinology"},{"key":"1041_CR95","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1242\/dev.007120","volume":"135","author":"A Takatori","year":"2008","unstructured":"Takatori A, Geh E, Chen L, Zhang L, Meller J, Xia Y (2008) Differential transmission of MEKK1 morphogenetic signals by JNK1 and JNK2. Development 135:23\u201332. https:\/\/doi.org\/10.1242\/dev.007120","journal-title":"Development"},{"key":"1041_CR96","doi-asserted-by":"publisher","unstructured":"Tang P, Wang X, Zhang M, Huang S, Lin C, Yan F, Deng Y, Zhang L, Zhang L (2019) Activin B stimulates mouse Vibrissae Growth and regulates cell proliferation and cell cycle progression of Hair Matrix cells through ERK Signaling. Int J Mol Sci 20. https:\/\/doi.org\/10.3390\/ijms20040853","DOI":"10.3390\/ijms20040853"},{"key":"1041_CR97","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.mce.2004.02.007","volume":"225","author":"TB Thompson","year":"2004","unstructured":"Thompson TB, Cook RW, Chapman SC, Jardetzky TS, Woodruff TK (2004) Beta A versus beta B: is it merely a matter of expression? Mol Cell Endocrinol 225:9\u201317. https:\/\/doi.org\/10.1016\/j.mce.2004.02.007","journal-title":"Mol Cell Endocrinol"},{"key":"1041_CR98","doi-asserted-by":"publisher","first-page":"40788","DOI":"10.1074\/jbc.M006114200","volume":"275","author":"K Tsuchida","year":"2000","unstructured":"Tsuchida K, Arai KY, Kuramoto Y, Yamakawa N, Hasegawa Y, Sugino H (2000) Identification and characterization of a novel follistatin-like protein as a binding protein for the TGF-beta family. J Biol Chem 275:40788\u201340796. https:\/\/doi.org\/10.1074\/jbc.M006114200","journal-title":"J Biol Chem"},{"key":"1041_CR99","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.mce.2004.03.009","volume":"220","author":"K Tsuchida","year":"2004","unstructured":"Tsuchida K, Nakatani M, Yamakawa N, Hashimoto O, Hasegawa Y, Sugino H (2004) Activin isoforms signal through type I receptor serine\/threonine kinase ALK7. Mol Cell Endocrinol 220:59\u201365. https:\/\/doi.org\/10.1016\/j.mce.2004.03.009","journal-title":"Mol Cell Endocrinol"},{"key":"1041_CR100","doi-asserted-by":"publisher","unstructured":"Tzavlaki K, Moustakas A (2020) TGF-\u03b2 signaling. https:\/\/doi.org\/10.3390\/biom10030487. Biomolecules 10","DOI":"10.3390\/biom10030487"},{"key":"1041_CR101","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/321776a0","volume":"321","author":"W Vale","year":"1986","unstructured":"Vale W, Rivier J, Vaughan J, McClintock R, Corrigan A, Woo W, Karr D, Spiess J (1986) Purification and characterization of an FSH releasing protein from porcine ovarian follicular fluid. Nature 321:776\u2013779. https:\/\/doi.org\/10.1038\/321776a0","journal-title":"Nature"},{"key":"1041_CR102","doi-asserted-by":"publisher","unstructured":"Valer JA, S\u00e1nchez-de-Diego C, Pimenta-Lopes C, Rosa JL, Ventura F (2019) ACVR1 function in Health and Disease. Cells 8. https:\/\/doi.org\/10.3390\/cells8111366","DOI":"10.3390\/cells8111366"},{"key":"1041_CR103","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1054\/bjoc.1999.0886","volume":"82","author":"RH van Schaik","year":"2000","unstructured":"van Schaik RH, Wierikx CD, Timmerman MA, Oomen MH, van Weerden WM, van der Kwast TH, van Steenbrugge GJ, de Jong FH (2000) Variations in activin receptor, inhibin\/activin subunit and follistatin mRNAs in human prostate tumour tissues. Br J Cancer 82:112\u2013117. https:\/\/doi.org\/10.1054\/bjoc.1999.0886","journal-title":"Br J Cancer"},{"key":"1041_CR104","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s11154-021-09666-w","volume":"23","author":"S Vannuccini","year":"2022","unstructured":"Vannuccini S, Clemenza S, Rossi M, Petraglia F (2022) Hormonal treatments for endometriosis: the endocrine background. Rev Endocr Metab Disord 23:333\u2013355. https:\/\/doi.org\/10.1007\/s11154-021-09666-w","journal-title":"Rev Endocr Metab Disord"},{"key":"1041_CR105","first-page":"1989","volume":"27","author":"J Vogl","year":"2007","unstructured":"Vogl J, H\u00f6ing A, Schulze S, Kuhn C, Wiest I, Shabani N, Jeschke U, Mylonas I, Friese K (2007) Expression of inhibins in the endometrial carcinoma cell line RL-95-2 after stimulation with cortisol and estradiol. Anticancer Res 27:1989\u20131993","journal-title":"Anticancer Res"},{"key":"1041_CR106","doi-asserted-by":"publisher","first-page":"e111276","DOI":"10.1371\/journal.pone.0111276","volume":"9","author":"I Wacker","year":"2014","unstructured":"Wacker I, Behrens J (2014) Activin B antagonizes RhoA signaling to stimulate mesenchymal morphology and invasiveness of clear cell renal cell carcinomas. PLoS ONE 9:e111276. https:\/\/doi.org\/10.1371\/journal.pone.0111276","journal-title":"PLoS ONE"},{"key":"1041_CR107","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1128\/mcb.01184-07","volume":"29","author":"I Wacker","year":"2009","unstructured":"Wacker I, Sachs M, Knaup K, Wiesener M, Weiske J, Huber O, Ak\u00e7etin Z, Behrens J (2009) Key role for activin B in cellular transformation after loss of the Von Hippel-Lindau tumor suppressor. Mol Cell Biol 29:1707\u20131718. https:\/\/doi.org\/10.1128\/mcb.01184-07","journal-title":"Mol Cell Biol"},{"key":"1041_CR108","doi-asserted-by":"publisher","first-page":"e90575","DOI":"10.1371\/journal.pone.0090575","volume":"9","author":"P Walentowicz","year":"2014","unstructured":"Walentowicz P, Krintus M, Sadlecki P, Grabiec M, Mankowska-Cyl A, Sokup A, Walentowicz-Sadlecka M (2014) Serum inhibin A and inhibin B levels in epithelial ovarian cancer patients. PLoS ONE 9:e90575. https:\/\/doi.org\/10.1371\/journal.pone.0090575","journal-title":"PLoS ONE"},{"key":"1041_CR109","doi-asserted-by":"publisher","first-page":"9311","DOI":"10.1074\/jbc.M808763200","volume":"284","author":"KL Walton","year":"2009","unstructured":"Walton KL, Makanji Y, Wilce MC, Chan KL, Robertson DM, Harrison CA (2009) A common biosynthetic pathway governs the dimerization and secretion of inhibin and related transforming growth factor beta (TGFbeta) ligands. J Biol Chem 284:9311\u20139320. https:\/\/doi.org\/10.1074\/jbc.M808763200","journal-title":"J Biol Chem"},{"key":"1041_CR110","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.mce.2011.06.030","volume":"359","author":"KL Walton","year":"2012","unstructured":"Walton KL, Makanji Y, Harrison CA (2012) New insights into the mechanisms of activin action and inhibition. Mol Cell Endocrinol 359:2\u201312. https:\/\/doi.org\/10.1016\/j.mce.2011.06.030","journal-title":"Mol Cell Endocrinol"},{"key":"1041_CR111","doi-asserted-by":"publisher","first-page":"12052","DOI":"10.1038\/ncomms12052","volume":"7","author":"X Wang","year":"2016","unstructured":"Wang X, Fischer G, Hyv\u00f6nen M (2016) Structure and activation of pro-activin A. Nat Commun 7:12052. https:\/\/doi.org\/10.1038\/ncomms12052","journal-title":"Nat Commun"},{"key":"1041_CR112","doi-asserted-by":"publisher","first-page":"3011","DOI":"10.1016\/j.bbagen.2016.09.027","volume":"1861","author":"X Wang","year":"2017","unstructured":"Wang X, Tang P, Guo F, Zhang M, Chen Y, Yan Y, Tian Z, Xu P, Zhang L, Zhang L, Zhang L (2017) RhoA regulates activin B-induced stress fiber formation and migration of bone marrow-derived mesenchymal stromal cell through distinct signaling. Biochim Biophys Acta Gen Subj 1861:3011\u20133018. https:\/\/doi.org\/10.1016\/j.bbagen.2016.09.027","journal-title":"Biochim Biophys Acta Gen Subj"},{"key":"1041_CR113","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1002\/stem.2924","volume":"37","author":"X Wang","year":"2019","unstructured":"Wang X, Tang P, Guo F, Zhang M, Yan Y, Huang M, Chen Y, Zhang L, Zhang L (2019) mDia1 and Cdc42 regulate activin B-Induced Migration of Bone Marrow-derived mesenchymal stromal cells. Stem Cells 37:150\u2013162. https:\/\/doi.org\/10.1002\/stem.2924","journal-title":"Stem Cells"},{"key":"1041_CR114","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1002\/pros.20949","volume":"69","author":"SK Watson","year":"2009","unstructured":"Watson SK, Woolcock BW, Fee JN, Bainbridge TC, Webber D, Kinahan TJ, Lam WL, Vielkind JR (2009) Minimum altered regions in early prostate cancer progression identified by high resolution whole genome tiling path BAC array comparative hybridization. Prostate 69:961\u2013975. https:\/\/doi.org\/10.1002\/pros.20949","journal-title":"Prostate"},{"key":"1041_CR115","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1093\/humupd\/dmv058","volume":"22","author":"R Wijayarathna","year":"2016","unstructured":"Wijayarathna R, de Kretser DM (2016) Activins in reproductive biology and beyond. Hum Reprod Update 22:342\u2013357. https:\/\/doi.org\/10.1093\/humupd\/dmv058","journal-title":"Hum Reprod Update"},{"key":"1041_CR116","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1111\/andr.12682","volume":"7","author":"R Wijayarathna","year":"2019","unstructured":"Wijayarathna R, Hedger MP (2019) Activins, follistatin and immunoregulation in the epididymis. Andrology 7:703\u2013711. https:\/\/doi.org\/10.1111\/andr.12682","journal-title":"Andrology"},{"key":"1041_CR117","first-page":"97","volume":"17","author":"S Worbs","year":"2007","unstructured":"Worbs S, Shabani N, Mayr D, Gingelmaier A, Makrigiannakis A, Kuhn C, Jeschke U, Kupka MS, Friese K, Mylonas I (2007) Expression of the inhibin\/activin subunits (-alpha, -betaA and -betab) in normal and carcinogenic endometrial tissue: possible immunohistochemical differentiation markers. Oncol Rep 17:97\u2013104","journal-title":"Oncol Rep"},{"key":"1041_CR118","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.immuni.2020.12.010","volume":"54","author":"B Wu","year":"2021","unstructured":"Wu B, Zhang S, Guo Z, Bi Y, Zhou M, Li P, Seyedsadr M, Xu X, Li JL, Markovic-Plese S, Wan YY (2021) The TGF-\u03b2 superfamily cytokine Activin-A is induced during autoimmune neuroinflammation and drives pathogenic Th17 cell differentiation. Immunity 54:308\u2013323e306. https:\/\/doi.org\/10.1016\/j.immuni.2020.12.010","journal-title":"Immunity"},{"key":"1041_CR119","doi-asserted-by":"publisher","first-page":"1097234","DOI":"10.3389\/fgene.2022.1097234","volume":"13","author":"C Xin","year":"2022","unstructured":"Xin C, Lai Y, Ji L, Wang Y, Li S, Hao L, Zhang W, Meng R, Xu J, Hong Y, Lou Z (2022) A novel 9-gene signature for the prediction of postoperative recurrence in stage II\/III colorectal cancer. Front Genet 13:1097234. https:\/\/doi.org\/10.3389\/fgene.2022.1097234","journal-title":"Front Genet"},{"key":"1041_CR120","doi-asserted-by":"publisher","first-page":"31659","DOI":"10.18632\/oncotarget.5229","volume":"6","author":"S Xiong","year":"2015","unstructured":"Xiong S, Klausen C, Cheng JC, Zhu H, Leung PC (2015) Activin B induces human endometrial cancer cell adhesion, migration and invasion by up-regulating integrin \u03b23 via SMAD2\/3 signaling. Oncotarget 6:31659\u201331673. https:\/\/doi.org\/10.18632\/oncotarget.5229","journal-title":"Oncotarget"},{"key":"1041_CR121","doi-asserted-by":"publisher","first-page":"40060","DOI":"10.18632\/oncotarget.9483","volume":"7","author":"S Xiong","year":"2016","unstructured":"Xiong S, Klausen C, Cheng JC, Leung PC (2016) Activin B promotes endometrial cancer cell migration by down-regulating E-cadherin via SMAD-independent MEK-ERK1\/2-SNAIL signaling. Oncotarget 7:40060\u201340072. https:\/\/doi.org\/10.18632\/oncotarget.9483","journal-title":"Oncotarget"},{"key":"1041_CR122","doi-asserted-by":"publisher","first-page":"153303382097327","DOI":"10.1177\/1533033820973270","volume":"19","author":"Z Xu","year":"2020","unstructured":"Xu Z, Li Y, Cui Y, Guo Y (2020) Identifications of candidate genes significantly Associated with rectal Cancer by Integrated Bioinformatics Analysis. Technol Cancer Res Treat 19:1533033820973270. https:\/\/doi.org\/10.1177\/1533033820973270","journal-title":"Technol Cancer Res Treat"},{"key":"1041_CR123","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.cytogfr.2015.11.005","volume":"27","author":"D Yadin","year":"2016","unstructured":"Yadin D, Knaus P, Mueller TD (2016) Structural insights into BMP receptors: specificity, activation and inhibition. Cytokine Growth Factor Rev 27:13\u201334. https:\/\/doi.org\/10.1016\/j.cytogfr.2015.11.005","journal-title":"Cytokine Growth Factor Rev"},{"key":"1041_CR124","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1016\/s0002-9378(97)70090-5","volume":"177","author":"K Yamashita","year":"1997","unstructured":"Yamashita K, Yamoto M, Shikone T, Minami S, Imai M, Nishimori K, Nakano R (1997) Production of inhibin A and inhibin B in human ovarian sex cord stromal tumors. Am J Obstet Gynecol 177:1450\u20131457. https:\/\/doi.org\/10.1016\/s0002-9378(97)70090-5","journal-title":"Am J Obstet Gynecol"},{"key":"1041_CR125","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/s0002-9378(99)70206-1","volume":"180","author":"K Yamashita","year":"1999","unstructured":"Yamashita K, Yamoto M, Shikone T, Minami S, Nakano R (1999) Immunohistochemical localization of inhibin and activin subunits in human epithelial ovarian tumors. Am J Obstet Gynecol 180:316\u2013322. https:\/\/doi.org\/10.1016\/s0002-9378(99)70206-1","journal-title":"Am J Obstet Gynecol"},{"key":"1041_CR126","doi-asserted-by":"publisher","first-page":"154460","DOI":"10.1016\/j.prp.2023.154460","volume":"245","author":"X Yang","year":"2023","unstructured":"Yang X, Jia Q, Zou Z, Liu X, Li X, Chen H, Ma H, Chen L (2023) INHBB promotes tumor aggressiveness and stemness of glioblastoma via activating EGFR signaling. Pathol Res Pract 245:154460. https:\/\/doi.org\/10.1016\/j.prp.2023.154460","journal-title":"Pathol Res Pract"},{"key":"1041_CR127","doi-asserted-by":"publisher","unstructured":"Yin Y, Yang S, Huang Z, Yang Z, Zhang C, He Y (2024) RNA methylation-related genes INHBB and SOWAHA are associated with MSI status in colorectal cancer patients and may serve as prognostic markers for predicting immunotherapy efficacy. https:\/\/doi.org\/10.1093\/carcin\/bgae004. Carcinogenesis","DOI":"10.1093\/carcin\/bgae004"},{"key":"1041_CR128","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3181\/00379727-186-42611a","volume":"186","author":"SY Ying","year":"1987","unstructured":"Ying SY (1987) Inhibins and activins: chemical properties and biological activity. Proc Soc Exp Biol Med 186:253\u2013264. https:\/\/doi.org\/10.3181\/00379727-186-42611a","journal-title":"Proc Soc Exp Biol Med"},{"key":"1041_CR129","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1210\/edrv-9-2-267","volume":"9","author":"SY Ying","year":"1988","unstructured":"Ying SY (1988) Inhibins, activins, and follistatins: gonadal proteins modulating the secretion of follicle-stimulating hormone. Endocr Rev 9:267\u2013293. https:\/\/doi.org\/10.1210\/edrv-9-2-267","journal-title":"Endocr Rev"},{"key":"1041_CR130","doi-asserted-by":"publisher","first-page":"933862","DOI":"10.3389\/fgene.2022.933862","volume":"13","author":"W Yu","year":"2022","unstructured":"Yu W, He G, Zhang W, Ye Z, Zhong Z, Huang S (2022) INHBB is a novel prognostic biomarker and correlated with immune infiltrates in gastric cancer. Front Genet 13:933862. https:\/\/doi.org\/10.3389\/fgene.2022.933862","journal-title":"Front Genet"},{"key":"1041_CR131","doi-asserted-by":"publisher","first-page":"6909672","DOI":"10.1155\/2020\/6909672","volume":"2020","author":"J Yuan","year":"2020","unstructured":"Yuan J, Xie A, Cao Q, Li X, Chen J (2020) INHBB is a Novel Prognostic Biomarker Associated with Cancer-promoting pathways in Colorectal Cancer. Biomed Res Int 2020:6909672. https:\/\/doi.org\/10.1155\/2020\/6909672","journal-title":"Biomed Res Int"},{"key":"1041_CR132","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1007\/s12032-011-0114-7","volume":"29","author":"F Zeng","year":"2012","unstructured":"Zeng F, Xu G, Zhou T, Yang C, Wang X, Peng C, Zhou H (2012) Reduced expression of activin receptor-like kinase 7 in breast cancer is associated with tumor progression. Med Oncol 29:2519\u20132526. https:\/\/doi.org\/10.1007\/s12032-011-0114-7","journal-title":"Med Oncol"},{"key":"1041_CR133","doi-asserted-by":"publisher","unstructured":"Zessner-Spitzenberg J, Thomas AL, Krett NL, Jung B (2019) TGF\u03b2 and activin A in the tumor microenvironment in colorectal cancer. Gene Rep 17. https:\/\/doi.org\/10.1016\/j.genrep.2019.100501","DOI":"10.1016\/j.genrep.2019.100501"},{"key":"1041_CR134","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1128\/mcb.25.1.60-65.2005","volume":"25","author":"L Zhang","year":"2005","unstructured":"Zhang L, Deng M, Parthasarathy R, Wang L, Mongan M, Molkentin JD, Zheng Y, Xia Y (2005) MEKK1 transduces activin signals in keratinocytes to induce actin stress fiber formation and migration. Mol Cell Biol 25:60\u201365. https:\/\/doi.org\/10.1128\/mcb.25.1.60-65.2005","journal-title":"Mol Cell Biol"},{"key":"1041_CR135","doi-asserted-by":"publisher","first-page":"e25143","DOI":"10.1371\/journal.pone.0025143","volume":"6","author":"M Zhang","year":"2011","unstructured":"Zhang M, Liu NY, Wang XE, Chen YH, Li QL, Lu KR, Sun L, Jia Q, Zhang L, Zhang L (2011) Activin B promotes epithelial wound healing in vivo through RhoA-JNK signaling pathway. PLoS ONE 6:e25143. https:\/\/doi.org\/10.1371\/journal.pone.0025143","journal-title":"PLoS ONE"},{"key":"1041_CR136","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.3727\/096368913x666999","volume":"23","author":"M Zhang","year":"2014","unstructured":"Zhang M, Sun L, Wang X, Chen S, Kong Y, Liu N, Chen Y, Jia Q, Zhang L, Zhang L (2014) Activin B promotes BMSC-Mediated cutaneous Wound Healing by regulating Cell Migration via the JNK-ERK Signaling Pathway. Cell Transpl 23:1061\u20131073. https:\/\/doi.org\/10.3727\/096368913x666999","journal-title":"Cell Transpl"},{"key":"1041_CR137","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1007\/s11255-015-1115-9","volume":"47","author":"Y Zhang","year":"2015","unstructured":"Zhang Y, Wang S, Liu S, Li C, Wang J (2015) Role of Smad signaling in kidney disease. Int Urol Nephrol 47:1965\u20131975. https:\/\/doi.org\/10.1007\/s11255-015-1115-9","journal-title":"Int Urol Nephrol"},{"key":"1041_CR138","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.biocel.2017.04.004","volume":"87","author":"L Zhang","year":"2017","unstructured":"Zhang L, Xu P, Wang X, Zhang M, Yan Y, Chen Y, Zhang L, Zhang L (2017) Activin B regulates adipose-derived mesenchymal stem cells to promote skin wound healing via activation of the MAPK signaling pathway. Int J Biochem Cell Biol 87:69\u201376. https:\/\/doi.org\/10.1016\/j.biocel.2017.04.004","journal-title":"Int J Biochem Cell Biol"},{"key":"1041_CR139","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1002\/jcsm.12461","volume":"10","author":"X Zhong","year":"2019","unstructured":"Zhong X, Pons M, Poirier C, Jiang Y, Liu J, Sandusky GE, Shahda S, Nakeeb A, Schmidt CM, House MG, Ceppa EP, Zyromski NJ, Liu Y, Jiang G, Couch ME, Koniaris LG, Zimmers TA (2019) The systemic activin response to pancreatic cancer: implications for effective cancer cachexia therapy. J Cachexia Sarcopenia Muscle 10:1083\u20131101. https:\/\/doi.org\/10.1002\/jcsm.12461","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"1041_CR140","doi-asserted-by":"publisher","first-page":"3416","DOI":"10.1111\/cas.13780","volume":"109","author":"G Zou","year":"2018","unstructured":"Zou G, Ren B, Liu Y, Fu Y, Chen P, Li X, Luo S, He J, Gao G, Zeng Z, Xiong W, Li G, Huang Y, Xu K, Zhang W (2018) Inhibin B suppresses anoikis resistance and migration through the transforming growth factor-\u03b2 signaling pathway in nasopharyngeal carcinoma. Cancer Sci 109:3416\u20133427. https:\/\/doi.org\/10.1111\/cas.13780","journal-title":"Cancer Sci"},{"key":"1041_CR141","doi-asserted-by":"publisher","first-page":"593310","DOI":"10.3389\/fmolb.2021.593310","volume":"8","author":"ML Zou","year":"2021","unstructured":"Zou ML, Chen ZH, Teng YY, Liu SY, Jia Y, Zhang KW, Sun ZL, Wu JJ, Yuan ZD, Feng Y, Li X, Xu RS, Yuan FL (2021) The smad dependent TGF-\u03b2 and BMP signaling pathway in bone remodeling and therapies. Front Mol Biosci 8:593310. https:\/\/doi.org\/10.3389\/fmolb.2021.593310","journal-title":"Front Mol Biosci"}],"container-title":["Journal of Physiology and Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13105-024-01041-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13105-024-01041-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13105-024-01041-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T09:10:55Z","timestamp":1735377055000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13105-024-01041-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,26]]},"references-count":141,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["1041"],"URL":"https:\/\/doi.org\/10.1007\/s13105-024-01041-y","relation":{},"ISSN":["1138-7548","1877-8755"],"issn-type":[{"value":"1138-7548","type":"print"},{"value":"1877-8755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,26]]},"assertion":[{"value":"20 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}